Good morning ... Confirmation hearings may not be what they used to be, pre-nuclear option, but even so, if nominee Alex Azar can get all the way to HHS without committing to at least some sort of formal review of whether to fund Affordable Care Act outreach, I'll be surprised.
When President Trump needed to find his first Health and Human Services secretary, at a time when his top priority was pushing Congress to repeal the Affordable Care Act, he went with a member of Congress. Now, with the repeal effort in a ditch, he's chosen someone who knows how to navigate the bureaucracy to make big changes administratively.
Alex Azar, Trump's pick to succeed former HHS secretary Tom Price, worked at HHS in the George W. Bush administration, first as its general counsel, then as deputy secretary. Both of those positions are deeply involved in the regulatory process.
"He seems like the right guy," said Tevi Troy, a conservative scholar who worked with Azar while Azar was at HHS and Troy at the White House. Troy later succeeded Azar as HHS deputy secretary.
The bottom line: Although Trump keeps insisting he wants Congress to try again on ACA repeal, picking Azar suggests a much stronger focus on administrative action.
One useful thing: "He seems to know everybody," Troy said.
Another tea leaf we can pretty easily read from Azar's selection: Trump isn't going to do much on his campaign promise to stop pharmaceutical companies from "getting away with murder." Azar is a veteran of drug giant Eli Lilly. And his ideology is basically in line with other conservative business leaders.
Go deeper: My colleague Bob Herman took a deep dive into Azar's tenure at Lilly, as well as his many appearances on Fox Business. Here's what he found:
What they're saying: Per Spencer Perlman, a health care analyst at Veda Partners: "We expect that HHS under Mr. Azar's leadership will continue to pursue relatively pharma-friendly approaches to drug pricing, such as value-based purchasing initiatives and cutting red tape at the Food and Drug Administration."
Be smart: Democrats have already telegraphed pretty clearly that Azar's industry connections will be their primary line of questioning/attack during his confirmation process.
Trump said last week that the shooting that left 26 people dead at First Baptist Church in Sutherland Springs, Texas, was "a mental health problem," not a gun problem. If that's the case, then what's the administration's record so far on mental health issues?
My colleague Alayna Treene took a close look, and found that Trump hasn't done much to solve the problem he has diagnosed.
Trump's budget proposed funding cuts for mental health services.
Trump reversed an Obama-era regulation that made it harder for people with mental health issues to buy guns.
The other side: White House deputy press secretary Hogan Gidley said the administration has encouraged states to apply for waivers that would exempt them from a Medicaid rule limiting the size of residential treatment facilities that can get federal Medicaid funding. "This waiver frees up federal dollars to help more people diagnosed with mental health issues," Gidley said.
Many current ACA enrollees received renewal notices that made their premiums look way too high — another side effect of the sudden disappearance of the law's cost-sharing payments. The Kaiser Family Foundation flagged this issue yesterday, with a photo of one couple's renewal notice, which said their costs would be going up by more than 740%.
The issue: Renewal notices give consumers an estimate of their new premium, by applying the subsidy they received the year before. That's been the case all along, but produced especially surprising (and inaccurate) results this year because premiums and subsidies have both increased so dramatically.
Reality check: If the couple who sent their renewal notice in to Kaiser hadn't been eligible for the ACA's premium subsidies, they'd still be on the hook for nearly $3,000 a month in premiums.
Hospital lobbying groups and individual systems are making good on their threat to try to halt the Trump administration's changes to the 340B drug discount program — changes that would cut $1.6 billion from hospital budgets next year. They have formally filed a lawsuit challenging Trump's new policy, which was finalized earlier this month.
What we're watching today: HELP Committee hearing on gene editing (10am, livestream here).
What we're watching this week: Surgeon General Jerome Adams testifies Wednesday at a HELP Committee hearing on "encouraging healthy communities."
Senate Appropriations subcommittee hearing Wednesday on the VA's efforts to combat opioid overuse.
Have you ever worked with Azar? What's he like? Do you have any photos we can use? email@example.com.